Results 281 to 290 of about 332,508 (311)
Some of the next articles are maybe not open access.
Measurement of Type I Interferon Production
Current Protocols in Immunology, 2011AbstractThe Basic Protocol in this unit describes measurement of murine interferon (IFN)α/β by intracellular staining for these cytokines and detection by flow cytometry. Alternate protocols detail an enzyme‐linked immunoabsorbent assay (ELISA) for IFNα and a biological assay to measure IFN.
Rosalind E, Seeds, Joanna L, Miller
openaire +2 more sources
Journal of Interferon & Cytokine Research, 2016
As in bacterial infections and endotoxin shock, type I interferons (IFNs) also have complex and often opposing effects in various models of autoimmune disease. We have shown that type I IFN paradoxically inhibits autoimmune diabetes in the nonobese diabetic mouse (NOD) and biobreeding (BB) rat.
Douglas, Sobel +2 more
openaire +2 more sources
As in bacterial infections and endotoxin shock, type I interferons (IFNs) also have complex and often opposing effects in various models of autoimmune disease. We have shown that type I IFN paradoxically inhibits autoimmune diabetes in the nonobese diabetic mouse (NOD) and biobreeding (BB) rat.
Douglas, Sobel +2 more
openaire +2 more sources
Virologie (Montrouge, France)
Type I interferons (IFNa/b) form a family of related cytokines that include INFa, b, e/s, j, x (human) and limitin (mouse). These cytokines exert a potent antiviral activity, control cell proliferation and modulate the immune response. They are used in the fight against viral infections, tumors, and multiple sclerosis.
S, Delhaye +4 more
openaire +1 more source
Type I interferons (IFNa/b) form a family of related cytokines that include INFa, b, e/s, j, x (human) and limitin (mouse). These cytokines exert a potent antiviral activity, control cell proliferation and modulate the immune response. They are used in the fight against viral infections, tumors, and multiple sclerosis.
S, Delhaye +4 more
openaire +1 more source
Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes
Cell, 2016Juan L Mendoza +2 more
exaly

